Patel Sanj K

CHAIRMAN & CEO, DirectorKiniksa Pharmaceuticals International, plc (KNSA) · full profile →Form 4 · filed Apr 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$26.4M
Net Open-Market Flow
-$26.4M
Transactions
14
10 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 30, 2026Option exercise(M)2K$30.93$66K2K
Apr 30, 2026Sell(S)2K$54.01$116K0
Apr 29, 2026Option exercise(M)23K$30.93$697K23K
Apr 29, 2026Sell(S)23K$54.01$1.2M0
Apr 28, 2026Sell(S)244K$52.02$12.7M52K
Apr 28, 2026Sell(S)52K$54.02$2.8M0
Apr 28, 2026Option exercise(M)432K$10.36$4.5M432K
Apr 28, 2026Option exercise(M)52K$30.93$1.6M484K
Apr 28, 2026Sell(S)75K$50.43$3.8M409K
Apr 28, 2026Sell(S)114K$51.47$5.9M295K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 30, 2026Option exercise(M)2K$049K
Apr 29, 2026Option exercise(M)23K$051K
Apr 28, 2026Option exercise(M)432K$00
Apr 28, 2026Option exercise(M)52K$073K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001532218-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.